PFR | Accession | Description | Modifications | Length | Confidence |
---|---|---|---|---|---|
160331 | Q16778 | Histone H2B type 2-E | 59 | ![]() |
|
160332 | P06454-1 | Prothymosin alpha | N-Terminal Acetylation, Phosphorylation@2, Phosphorylation@10, Acetylation@15 | 111 | ![]() |
160333 | P06454-1 | Prothymosin alpha | N-Terminal Acetylation, Phosphorylation@2, Phosphorylation@14, Acetylation@15 | 111 | ![]() |
160334 | P06454-1 | Prothymosin alpha | N-Terminal Acetylation, Phosphorylation@2, Phosphorylation@13, Acetylation@15 | 111 | ![]() |
160335 | Q93079 | Histone H2B type 1-H | N6-crotonyl-L-lysine@6, Acetylation@13 | 124 | ![]() |
160336 | Q93079 | Histone H2B type 1-H | N6-crotonyl-L-lysine@6, Acetylation@16 | 124 | ![]() |
160337 | Q93079 | Histone H2B type 1-H | Acetylation@6, N6-crotonyl-L-lysine@13 | 124 | ![]() |
160338 | Q93079 | Histone H2B type 1-H | N6-crotonyl-L-lysine@12, Acetylation@13 | 124 | ![]() |
160339 | Q93079 | Histone H2B type 1-H | N6-crotonyl-L-lysine@13, Acetylation@17 | 124 | ![]() |
160340 | Q93079 | Histone H2B type 1-H | Acetylation@6, N6-crotonyl-L-lysine@16 | 124 | ![]() |
160341 | Q93079 | Histone H2B type 1-H | Acetylation@12, N6-crotonyl-L-lysine@13 | 124 | ![]() |
160342 | Q93079 | Histone H2B type 1-H | N6-crotonyl-L-lysine@13, Acetylation@16 | 124 | ![]() |
160343 | Q93079 | Histone H2B type 1-H | Acetylation@6, N6-crotonyl-L-lysine@12 | 124 | ![]() |
160344 | Q93079 | Histone H2B type 1-H | N6-crotonyl-L-lysine@12, Acetylation@17 | 124 | ![]() |
160345 | P62280 | 40S ribosomal protein S11 | N-Terminal Acetylation | 61 | ![]() |
160346 | Q5QNW6-2 | Histone H2B type 2-F | 125 | ![]() |
|
160347 | Q16778 | Histone H2B type 2-E | 41 | ![]() |
|
160348 | P52566 | Rho GDP-dissociation inhibitor 2 | Acetylation@25 | 54 | ![]() |
160349 | Q93079 | Histone H2B type 1-H | N6-crotonyl-L-lysine@6, Acetylation@17 | 124 | ![]() |
160350 | Q93079 | Histone H2B type 1-H | N6-crotonyl-L-lysine@6, Acetylation@12 | 124 | ![]() |